| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-10 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-10 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |